These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17365091)

  • 1. Behavioural intervention effects in dysarthria following stroke: communication effectiveness, intelligibility and dysarthria impact.
    Mackenzie C; Lowit A
    Int J Lang Commun Disord; 2007; 42(2):131-53. PubMed ID: 17365091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved status following behavioural intervention in a case of severe dysarthria with stroke aetiology.
    Mackenzie C; Lowit A
    Int J Speech Lang Pathol; 2012 Aug; 14(4):318-28. PubMed ID: 22348261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The living with dysarthria group: implementation and feasibility of a group intervention for people with dysarthria following stroke and family members.
    Mackenzie C; Paton G; Kelly S; Brady M; Muir M
    Int J Lang Commun Disord; 2012; 47(6):709-24. PubMed ID: 23121529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-speech oro-motor exercises in post-stroke dysarthria intervention: a randomized feasibility trial.
    Mackenzie C; Muir M; Allen C; Jensen A
    Int J Lang Commun Disord; 2014; 49(5):602-17. PubMed ID: 24889103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria.
    Park S; Theodoros D; Finch E; Cardell E
    Am J Speech Lang Pathol; 2016 Feb; 25(1):97-110. PubMed ID: 26882004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive treatment of dysarthria secondary to stroke.
    Mahler LA; Ramig LO
    Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The short- and long-term effectiveness of the LSVT for dysarthria following TBI and stroke.
    Wenke RJ; Theodoros D; Cornwell P
    Brain Inj; 2008 Apr; 22(4):339-52. PubMed ID: 18365848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech intelligibility and perceptions of communication effectiveness by speakers with dysarthria following traumatic brain injury and their communication partners.
    McAuliffe MJ; Carpenter S; Moran C
    Brain Inj; 2010; 24(12):1408-15. PubMed ID: 20858025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living with acquired dysarthria: the speaker's perspective.
    Walshe M; Miller N
    Disabil Rehabil; 2011; 33(3):195-203. PubMed ID: 20735274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of boost articulation therapy (BArT) on intelligibility in adults with dysarthria.
    Mendoza Ramos V; Paulyn C; Van den Steen L; Hernandez-Diaz Huici ME; De Bodt M; Van Nuffelen G
    Int J Lang Commun Disord; 2021 Mar; 56(2):271-282. PubMed ID: 33484095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management.
    Atkinson-Clement C; Letanneux A; Baille G; Cuartero MC; Véron-Delor L; Robieux C; Berthelot M; Robert D; Azulay JP; Defebvre L; Ferreira J; Eusebio A; Moreau C; Pinto S
    Neurodegener Dis; 2019; 19(1):12-21. PubMed ID: 31112944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury.
    Morgan A; Liegeois F; Occomore L
    Brain Inj; 2007 Oct; 21(11):1183-93. PubMed ID: 17896211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smartphone-Based Speech Therapy for Poststroke Dysarthria: Pilot Randomized Controlled Trial Evaluating Efficacy and Feasibility.
    Kim Y; Kim M; Kim J; Song TJ
    J Med Internet Res; 2024 Apr; 26():e56417. PubMed ID: 38509662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of level of presentation to listeners on scaled speech intelligibility of speakers with dysarthria.
    Kim Y; Kuo C
    Folia Phoniatr Logop; 2012; 64(1):26-33. PubMed ID: 21952405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic changes in the speech of children with cerebral palsy following an intensive program of dysarthria therapy.
    Pennington L; Lombardo E; Steen N; Miller N
    Int J Lang Commun Disord; 2018 Jan; 53(1):182-195. PubMed ID: 28714530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating interactional competencies in Parkinson's disease: the potential benefits of a conversation analytic approach.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Int J Lang Commun Disord; 2011; 46(5):497-509. PubMed ID: 21899668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysarthria following acute ischemic stroke: Prospective evaluation of characteristics, type and severity.
    De Cock E; Oostra K; Bliki L; Volkaerts AS; Hemelsoet D; De Herdt V; Batens K
    Int J Lang Commun Disord; 2021 May; 56(3):549-557. PubMed ID: 33580596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.